4D pharma plc – NASDAQ:LBPSW
4D pharma stock price today
4D pharma stock price monthly change
4D pharma stock price quarterly change
4D pharma stock price yearly change
4D pharma key metrics
Market Cap | N/A |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | -0.3 |
Revenue | 137.5K |
EBITDA | -7.57M |
Income | -6.86M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | -5512.36% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for free4D pharma stock price history
4D pharma stock forecast
4D pharma financial statements
| Jun 2020 | 137.5K | -6.86M | -4991.27% |
|---|
| Jun 2020 | 39946000 | 8.48M | 21.25% |
|---|---|---|---|
| Dec 2020 | 35421000 | 7.45M | 21.04% |
| Jun 2021 | 47647000 | 7.98M | 16.76% |
| Dec 2021 | 58794000 | 26.37M | 44.87% |
4D pharma alternative data
| Aug 2023 | 127 |
|---|---|
| Sep 2023 | 127 |
| Oct 2023 | 127 |
| Nov 2023 | 127 |
| Dec 2023 | 127 |
| Jan 2024 | 127 |
| Feb 2024 | 127 |
| Mar 2024 | 127 |
| Apr 2024 | 127 |
| May 2024 | 127 |
| Jun 2024 | 127 |
| Jul 2024 | 127 |
4D pharma other data
-
What's the price of 4D pharma stock today?
One share of 4D pharma stock can currently be purchased for approximately $0.04.
-
When is 4D pharma's next earnings date?
Unfortunately, 4D pharma's (LBPSW) next earnings date is currently unknown.
-
Does 4D pharma pay dividends?
No, 4D pharma does not pay dividends.
-
What is 4D pharma's stock symbol?
4D pharma plc is traded on the NASDAQ under the ticker symbol "LBPSW".
-
What is 4D pharma's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of 4D pharma?
Shares of 4D pharma can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does 4D pharma have?
As Jul 2024, 4D pharma employs 127 workers.
-
When 4D pharma went public?
4D pharma plc is publicly traded company for more then 4 years since IPO on 23 Mar 2021.
-
What is 4D pharma's official website?
The official website for 4D pharma is 4dpharmaplc.com.
4D pharma company profile:
4D pharma plc
4dpharmaplc.comNASDAQ
127
Biotechnology
Healthcare
4D pharma plc, together with its subsidiaries, engages in the research, development, and production of live biotherapeutic products. The company's development programs include Blautix for irritable bowel syndrome and Thetanix for paediatric crohn's disease. It also develops immuno-oncology products comprising MRx0518, MRx0573, and MRx1299 for solid tumors, and MRx0518 for pancreatic cancer; respiratory products, such as MRx-4DP0004 for asthma and COVID-19; central nervous system products, including MRx0005 and MRx0029 for neurodegeneration; and platform products comprising vaccines and autoimmune. 4D pharma plc has a collaboration agreement with Merck & Co., Inc. to conduct a clinical trial evaluating the combination of Keytruda and MRx0518 in patients with solid tumours. The company was formerly known as Schosween 18 Limited. 4D pharma plc was founded in 2014 and is headquartered in Leeds, the United Kingdom.
Leeds,
CIK: 0001830162
:
:
